drugset / Trial / NCT00153179

Free Fatty Acids and Vascular Function in Subjects With Diabetes

NCT00153179

Phase 1/2 Completed 40 enrolled Brigham and Women's Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study will test the hypothesis that reduction in release of free fatty acids from adipocytes will restore insulin-mediated endothelium-dependent vasodilation and skeletal muscle glucose metabolism in subject with type 2 diabetes.

Timeline

Start
2005-09
Primary completion
2011-12
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acipimox Small molecule 250 mg Oral